This fall, RAP introduces two new funding opportunities for neuroscience researchers, a new award for health services research, and grant supplements to support diversity and inclusion.
UCSF scientists who identified the only human gene known to promote “natural short sleep” have discovered a second.
Researchers discovered a scorpion toxin that targets the “wasabi receptor,” which they think it can be used as a tool for studying chronic pain and inflammation, and may eventually lead to the development of new kinds of non-opioid pain relievers.
In a paper researchers describe a technique that uses a special version of CRISPR developed at UCSF to systematically alter the activity of genes in human neurons generated from stem cells, the first successful merger of stem cell-derived cell types and CRISPR screening technologies.
Study Suggests Tau Tangles, Not Amyloid Plaques, Drive Daytime Napping That Precedes DementiaUCSF scientists show that Alzheimer’s disease directly attacks brain regions responsible for wakefulness during the day.
Study Is Step Toward One Day Treating People with Speech LossUCSF scientists have for the first time decoded spoken words and phrases in real time from the brain signals that control speech.
Since 2017, UCSF researchers Winston Chiong and Eddie Chang have led a collaborative neuroethics research project funded by the NIH.
Places Among Nation’s Most Renowned for Excellence in 15 Adult SpecialtiesFor the 21st year, UCSF Health has been listed among the top 10 hospitals nationwide in the prestigious U.S. News & World Report’s Best Hospitals survey.
Discovery Could Inform Future MS Immunotherapies Brain damage associated with MS specifically targets a common class of brain cells called projection neurons
With New Commitment, Couple’s Total Giving to ‘UCSF: The Campaign’ Reaches $50MThe Susan and Bill Oberndorf Foundation has made a new commitment of $25 million to UCSF psychiatry and the neurosciences, bringing its total giving to "UCSF: The Campaign" to $50 million.